Also trades as: IBAB.BR (BRU) · $vol 0M

$18.00

+0.20 (+1.12%)

Weekly Expected Move ±4.0%

$17 $17 $18 $19 $19

OTC · Healthcare · Medical - Devices · Tech Score Sell · Power 49 · $527.9M mcap · 19M float · 0.0060% daily turnover · Short 92% of daily vol

Revenue

$620M +24.5% ▲

5Y CAGR: +14.7%

Gross Profit

$200M +20.2% ▲

5Y CAGR: +8.0%

Operating Income

$27M +38.9% ▲

5Y CAGR: -7.4%

Net Income

$13M +37.2% ▲

5Y CAGR: -16.8%

EPS (Diluted)

$0.43 +38.7% ▲

5Y CAGR: -16.7%

EBITDA

$41M +42.5% ▲

5Y CAGR: -3.0%

View Full Income Statement

Line Item	FY2021	FY2022	FY2023	FY2024	FY2025
Revenue	$313M	$361M	$429M	$498M	$620M
YoY Growth	+0.3%	+15.4%	+18.7%	+16.2%	+24.5%
Cost of Revenue	$205M	$235M	$294M	$332M	$420M
Gross Profit	$108M	$127M	$134M	$166M	$200M
Gross Margin	34.4%	35.1%	31.4%	33.3%	32.2%
R&D Expenses	$34M	$42M	$51M	$58M	$62M
SG&A Expenses	$59M	$74M	$80M	$91M	$110M
Operating Expenses	$94M	$122M	$129M	$146M	$172M
Operating Income	$13M	$5M	$5M	$20M	$27M
Operating Margin	4.3%	1.4%	1.2%	3.9%	4.4%
Interest Expense	$3M	$2M	$1M	$2M	$8M
Income Before Tax	$8M	-$430K	-$315K	$15M	$19M
Tax Expense	$4M	-$6M	$9M	$6M	$6M
Net Income	$4M	$6M	-$9M	$9M	$13M
Net Margin	1.2%	1.7%	-2.1%	1.9%	2.0%
EPS (Diluted)	$0.13	$0.20	$-0.31	$0.31	$0.43
EBITDA	$21M	$13M	$11M	$29M	$41M
Shares Outstanding	30M	30M	29M	29M	30M

Line Item	FY2022 Q4	FY2023 Q2	FY2023 Q4	FY2024 Q2	FY2024 Q4	FY2025 Q2	FY2025 Q4	FY2026 Q2
Revenue	$201M	$169M	$297M	$206M	$292M	$305M	$315M	$323M
Cost of Revenue	$137M	$124M	$170M	$137M	$196M	$215M	$206M	$214M
Gross Profit	$64M	$45M	$89M	$70M	$96M	$90M	$110M	$109M
Gross Margin	31.9%	26.6%	30.1%	33.8%	33.0%	29.5%	34.8%	33.6%
R&D Expenses	$22M	$24M	$24M	$27M	$31M	$31M	$31M	$36M
SG&A Expenses	$36M	$41M	$39M	$43M	$48M	$48M	$62M	$56M
Operating Expenses	$58M	$65M	$63M	$73M	$74M	$79M	$93M	$93M
Operating Income	$6M	-$20M	$26M	-$3M	$23M	$11M	$17M	$16M
Operating Margin	3.2%	-12.0%	8.7%	-1.4%	7.8%	3.5%	5.3%	5.0%
Interest Expense	$13M	$6M	-$5M	$5M	-$3M	$5M	$3M	$3M
Income Before Tax	-$5M	-$23M	$22M	-$7M	$22M	$1M	$18M	$12M
Tax Expense	-$9M	$5M	$4M	$3M	$2M	$4M	$2M	$3M
Net Income	$8M	-$27M	$18M	-$10M	$20M	-$3M	$15M	$9M
Net Margin	3.9%	-16.1%	6.1%	-5.0%	6.7%	-0.9%	4.8%	2.9%
EPS (Diluted)	$0.26	$-0.94	$0.62	$-0.35	$0.66	$-0.09	$0.52	$0.31
EBITDA	$9M	-$5M	$30M	-$372K	$32M	$13M	$24M	$24M
Shares Outstanding	30M	29M	29M	29M	30M	30M	29M	30M

IOBCF OTC